Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.16 USD | +5.79% | +9.79% | +111.73% |
May. 02 | Dyne Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 30 | Morgan Stanley Starts Dyne Therapeutics With Overweight Rating, $40 Price Target | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 14.06M | Capitalization | 2.46B |
---|---|---|---|---|---|
Net income 2024 * | -259M | Net income 2025 * | -292M | EV / Sales 2024 * | - |
Net cash position 2024 * | 191M | Net cash position 2025 * | 301M | EV / Sales 2025 * | 154 x |
P/E ratio 2024 * |
-9.08
x | P/E ratio 2025 * |
-8.6
x | Employees | 143 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.45% |
1 day | +5.79% | ||
1 week | +9.79% | ||
Current month | +11.26% | ||
1 month | +8.94% | ||
3 months | +16.41% | ||
6 months | +172.08% | ||
Current year | +111.73% |
Managers | Title | Age | Since |
---|---|---|---|
Jason Rhodes
FOU | Founder | 54 | 17-11-30 |
Rick Scalzo
DFI | Director of Finance/CFO | 38 | 19-11-30 |
John Najim
CTO | Chief Tech/Sci/R&D Officer | 48 | 19-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Edward Hurwitz
BRD | Director/Board Member | 60 | 18-10-31 |
David Lubner
BRD | Director/Board Member | 60 | 20-02-29 |
Dirk Kersten
BRD | Director/Board Member | 49 | 18-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - | |
0.02% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 28.16 | +5.79% | 650,219 |
24-05-13 | 26.62 | +2.38% | 959,621 |
24-05-10 | 26 | +0.19% | 538,840 |
24-05-09 | 25.95 | +1.01% | 1,008,522 |
24-05-08 | 25.69 | +0.16% | 464,282 |
Delayed Quote Nasdaq, May 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+111.73% | 2.33B | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- DYN Stock